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Abstract
Background: Proteolytic imbalance might determine arterial remodeling and plaque destabilization in atherosclerotic vessels. The aim of this
study was to examine differences in the patterns of metalloproteinases (MMPs) and MMP inhibitor (TIMP-1) expression in advanced human
atheromas, both in relation to the plaque features and the vascular bed involved. Methods and results: Immunohistochemistry for MMP-1,
-3, -9 and TIMP-1 as well as the collagen content were measured in vascular sections from patients undergoing peripheral revascularization
(carotid n= 11, femoral n= 23) and aorto-coronary bypass surgery (mammary arteries n= 20, as controls). Increased expression of all MMPs
was detected in atherosclerotic as compared with control sections (P<0.01). Aneurismal plaques showed a significant increase of MMP-1
and-3 and a reduction in total collagen (P<0.05) in relation to occlusive lesions. Calcification areas in atherosclerotic plaques were consistently
associated with increased TIMP-1 expression (P<0.01). Finally, MMP-9 expression was higher in occlusive lesions from carotid than femoral
arteries (P<0.01). Conclusions: Aneurysm lesions expressed higher MMP-1 and-3 expression than occlusive plaques, and MMP-9 was
mainly detected in carotid as compared with femoral arteries. TIMP-1 was associated with arterial calcification. These differences in the
MMPs/TIMP-1 expression might determine the evolution of advanced atherosclerotic plaques and contribute to its vulnerability.
© 2003 Elsevier Ireland Ltd. All rights reserved.
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1. Introduction
Atherosclerosis involves multiple processes including
endothelial dysfunction, inflammation, vascular prolifera-
tion and extracellular matrix (ECM) degradation. Advanced
atherosclerotic disease is characterized by rupture, hemor-
rhage and thrombus formation [1,2]. Converging lines of
evidence point to a dynamic regulation of collagen syn-
thesis and breakdown in the atherosclerotic plaque. The
net result, dissolution of collagenous matrix in the fibrous
cap due to overexpression of active metalloproteinases
(MMPs), renders this structure weak, friable and suscep-
tible to rupture when exposed to hemodynamic stress [3].
Moreover, during atherosclerosis, the proteolytic balance
shifts towards increased proteolysis causing degradation
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of ECM contributing to aneurysm formation [4]. MMPs
are zinc-dependent endopeptidases that degrade many
molecules of the ECM. They can be divided into four major
subclasses, generally based on substrate specificity; colla-
genases (MMP-1, MMP-8, MMP-13), gelatinases (MMP-2,
MMP-9), stromelysins (MMP-3, MMP-10, MMP-11), and
membrane-type (MT-MMPs). Immunohistochemistry stud-
ies have demonstrated that MMPs are expressed by cells
present within atheromas, but not in normal arteries [5,6].
Excessive or inappropriate expression of MMPs is known
to contribute to the pathogenesis of cardiovascular diseases
(atherosclerosis plaque rupture and aneurysm formation).
There is evidence of increased expression of some MMPs,
particularly gelatinases and/or stromelysin-1, in abdomi-
nal aortic aneurysms [7–10]. MMP activity is controlled
by specific inhibitors (TIMPs); four members of the tis-
sue inhibitor family have been identified: TIMP-1, -2, -3,
and -4 [11,12]. Their overexpression reduces neointimal
development in experimental models of vascular injury
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and may provide protection against plaque destabilization
[13,14].
Little is known as to the relative contribution of each
MMP and TIMP in determining the evolution of atheroscle-
rotic lesions. We hypothesized that the susceptibility for an
atherosclerotic vessel to develop occlusive or aneurismal
lesions could be determined by differences in MMPs ex-
pression. It is also unknown whether MMPs and/or TIMP-1
are expressed differently in atherosclerotic lesions depend-
ing on the affected segment of the arterial tree. Therefore,
we examined the expression of MMP-1, -3, -9 and TIMP-1
in advanced human atheroma both in relation to the plaque
features and the vascular bed involved.
2. Materials and methods
2.1. Vascular specimens
Vascular tissue samples were obtained from 36 male
patients (67.3 ± 1.6 years) undergoing peripheral revas-
cularization procedures (carotid endarterectomy= 11,
femoro-popliteal revascularization= 25). Surgical inter-
vention criteria were internal carotid stenosis > 75% and
critical limb ischemia due to femoro-popliteal obstruction
or femoral aneurysm (diameter > 20 mm). The following
cardiovascular risk factors were recorded preoperatively:
arterial hypertension (systolic blood pressure > 139 mm
Hg and/or diastolic blood pressure > 89 mm Hg and/or use
of antihypertensive drugs), dyslipidemia (total cholesterol
≥220 mg/dl and/or HDL cholesterol ≤40 mg/dl and/or LDL
cholesterol ≥140 mg/dl and/or use of cholesterol lowering
drugs), obesity (body mass index ≥30 kg/m2), smoking
(≥one cigarette a day), and diabetes (fasting glucose ≥126
mg/dl and/or use of oral antidiabetics).
Vascular mammary artery segments (n= 20) from patients
undergoing aorto-coronary bypass surgery (mean age 62.5
± 1.9 years) were used as controls.
The study protocol was approved by the Research Ethics
Committee of the University Clinic of Navarra, and written
informed consent was obtained for all participants.
2.2. Analysis of atherosclerotic lesions
Vascular segments were removed carefully at surgery
to preserve the plaque structure. The samples were cut
into pieces transversely and immediately fixed in 4%
paraformaldehyde for 4 h, before paraffin embedding. The
histological sections were stained with hematoxilin–eosin
and van Gieson and examined with a microscope (Nikon
Optiphot-2, Japan).
All peripheral samples corresponded to advanced
atherosclerotic plaques (types V–VIII), based on the AHA
histological classification [15]. They were divided into oc-
clusive or aneurismal, attending to surgical and histological
criteria as proposed by the Ad Hoc Committee on Report-
ing Standars [16]. Occlusive arterial disease was defined as
stenosis obstruction of the arterial vessel due to atheroscle-
rotic plaque enlargement resulting in impairment of blood
flow. Arterial aneurysm was defined as a permanent and
localized dilatation with at least 50% increase of the normal
vessel diameter.
2.3. Immunohistochemistry for MMPs and TIMP-1
Serial sections were analyzed by immunohistochem-
istry as previously described [17], using specific mono-
clonal antibodies anti-MMP-1 (2 g/ml, Oncogene, USA),
anti-MMP-3 (3.3 g/ml, Oncogene), anti-MMP-9 (1.3
g/ml, Oncogene) which recognize both active and latent
forms and a polyclonal antibody anti-TIMP-1 (20 g/ml,
Biogenesis, UK). All sections were incubated with sec-
ondary biotinylated antic-Fc (Dako, Denmark), developed
with avidin–biotin-peroxidase complex (ABC, Dako) and
3-3′-diaminobenzidine hydrochloride (Sigma, USA) and
counterstained with Harris’ hematoxylin.
Monoclonal anti CD-68 (0.2 g/ml, Dako), and
anti--actin (0.3 g/ml, Dako), were used for detection of
macrophages and smooth muscle cells (SMC), respectively.
A visual grading scale was used for assessing the exten-
sion of MMPs and TIMP-1 immunostaining as previously
reported [17]. Three observers characterized sections inde-
pendently in a blinded fashion, by comparison against a con-
trol section using the grading scale: 0= no positive cells;
1≤ 25% of the plaque area with positive cells; 2≤ 50%; and
3≥ 50%.
2.4. Staining of collagen by picrosirius red
Sirius red staining was used to identify interstitial colla-
gen on serial 3 m sections as described previously [18].
Vascular sections stained for collagen were analyzed using
a polarized filter, which characterized type I (red/yellow)
and type III (green) collagen fibrils [19]. Analysis of sir-
ius red collagen staining was performed with a personal
computer-based quantitative optimas 5.2 color image anal-
ysis. The percentage of the plaque area stained for collagen
types I and III was recorded.
2.5. Statistical analysis
Values are expressed as mean ± S.E.M. Differences
in the collagen content and proteolytic balance between
aneurysm and occlusive lesions were performed by
Mann–Whitney-U-test and regression analysis. Kendall’s
tau–b correlation was used to assess the association between
percentage of plaque area stained for collagen with values
for MMPs and TIMP-1 semiquantitive scores. Differences
in the proteolytic balance between femoral and carotid ar-
teries were studied by Fisher exact test and t-student or
Mann–Whitney-U-test, as appropriate. Statistical signifi-
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Table 1
Cardiovascular risk factors in patients undergoing revascularization procedures in relation to atherosclerotic plaque features
Control arteries (n= 20) Advanced atherosclerotic lesions
Total (n= 36) Occlusive (n= 23) Aneurysm (n= 13)
Age (year) 62.5 ± 1.9 67.3 ± 1.6 67.4 ± 2.0 66.7 ± 2.8
Hypertension (%) 60.9 58.6 57.1 62.5
Dyslipidemia (%) 52.2 71.4 71.4 71.4
Diabetes mellitus (%) 18.2 30.8 40 32.5
Obesity (%) 26.1 25.4 21.1 30.5
Smoking (%) 60.9 75.9 77.3 71.5
cance was indicated by a value of P<0.05. All calculations
were performed with spss 9.0.
3. Results
3.1. Immunohistochemistry for MMPs/TIMP-1 in control
and atherosclerotic human arteries
MMPs expression was measured in 36 arteries from pa-
tients undergoing revascularization procedures and present-
ing one or more cardiovascular risk factors. Samples were
divided into two groups: carotid endarterectomy (n= 11)
Fig. 1. Immunohistochemical and sirius red staining photographed under polarized light, of human advanced atherosclerotic lesion. Extense positive
signal for MMP-1 (panel A), MMP-3 (panel B) and MMP-9 (panel C) expression is shown, in contrast to a weaker TIMP-1 expression (panel D). Total
collagen was markedly reduced in areas stained for MMPs (Panel E). MMPs were mainly expressed in areas showing intense positivity for macrophage
(CD-68) staining (Panel F). Magnified detail of panel F shows a local accumulation of macrophages that could predispose to plaque rupture.
and femoral revascularization (n= 25). As control, we used
mammary arteries (n= 20) without macroscopic atheroscle-
rotic lesions from patients undergoing aorto-coronary by-
pass surgery. Both groups were of similar ages and had no
differences for cardiovascular risk factors (Table 1). Overall,
human advanced atherosclerotic lesions showed overexpres-
sion of all MMPs and TIMP-1, which appeared most abun-
dant in lipid- and macrophage-rich atheromatous compared
with fibrous (SMC-rich) plaques, and localized mostly in
regions prone to rupture and in areas surrounding the lipid
core (Fig. 1). Semiquantitative image analysis showed that
staining for MMP–1, -3, -9 and TIMP-1 antigen in athero-
matous plaques significantly (P<0.01) exceeded those in
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Table 2
Expression of individual MMPs and TIMP-1 in relation to atherosclerotic plaque features
Control arteries (n= 20) Advanced atherosclerotic lesions (n= 36)
Score 0 1 2 3 Median 0 1 2 3 Median
MMP-1 9 5 6 0 1 2 9 13 12 2**
MMP-3 8 12 0 0 1 4 13 15 4 2**
MMP-9 20 0 0 0 0 14 9 7 6 1**
TIMP-1 20 0 0 0 0 11 10 7 8 1**
The median values for the semiquantitative immunohistochemical score are shown. ** P<0.01 as compared with control arteries.
control arteries, which showed a weak immunoreactivity for
MMP-1 and MMP-3, whereas no positive signal for MMP-9
and TIMP-1 was detected (Table 2).
A great variability in the collagen content was ob-
served in atherosclerotic plaques, with the stained area
in advanced plaques being 64.7 ± 3.8% of the total area
(range 10.6–97.3%). As expected, the total collagen content
negatively correlated with MMP-1 expression (r=−0.3,
P<0.05). In general, the percentage of red fibers corre-
sponding to type I collagen exceeded the content of green
fibers corresponding to type III collagen (40.0 ± 4.0 vs.
25.0 ± 3.3%, P<0.01). The percentage of collagen type III
negatively correlated with MMP-1, -3, and -9 (r=−0.2,
r=−0.3 and r=−0.5, respectively, P<0.02), whereas no
correlation was observed for type I collagen.
Fig. 2. Percentage of scored values for MMP-1 and MMP-3 in aneurysm
(n= 13) and occlusive (n= 23) lesions. *, P<0.05 as compared with
occlusive lesions.
3.2. Expression of MMPs/TIMP-1 in aneurysm compared
with occlusive atherosclerotic disease
Human atherosclerotic plaques were separated by conven-
tional morphological characteristics into occlusive (n= 23,
63.9%) and aneurismal (n= 13, 36.1%). A significant in-
crease of MMP-1 and MMP-3 could be demonstrated in ar-
terial aneurysms in relation to occlusive lesions (P<0.05);
however, no differences in the expression of MMP-9 and
TIMP-1 were observed (Fig. 2). A significant reduction in
total collagen content was also found in aneurysm as com-
pared with occlusive plaques (53.2 ± 6.8 vs. 70.1 ± 4.2%,
P<0.05). The observed reduction was mainly due to a de-
crease in type I fibers (31.3 ± 5.9. vs. 44.1 ± 5.1%), in
contrast with the practically unaltered content in type III
collagen (22.0 ± 4.0 vs. 26.4 ± 4.5%) (Fig. 3).
Interestingly, in both aneurysm and occlusive lesions,
overexpression of TIMP-1 was consistently associated with
calcification areas in the atherosclerotic plaque (Fig. 4). The
observed increase in TIMP-1 expression correlated signifi-
cantly with the presence of type I collagen (r= 0.6, P<0.01)
under polarized light, thereby increasing the typeI/typeIII
collagen ratio when compared with noncalcified lesions
(5.9 ± 1.7 vs. 1.5 ± 0.3, P<0.02).
3.3. Expression of MMPs/TIMP-1 in relation to the
vascular bed
Atherosclerotic plaques were classified according to
vascular bed and morphological characteristics. As ex-
pected, femoral aneurysms (n= 13) showed higher MMP-1
(P<0.01) and MMP-3 (P<0.01) expression than femoral
occlusive lesions (n= 12). Said analysis could not be per-
formed on carotid arteries, since they were all occlusive.
Comparisons between occlusive lesions in relation to the
vascular bed involved, either carotid (n= 11) or femoral
(n= 12), were performed. Significant changes were ob-
served for the MMP-9 expression in different sections of
the arterial tree (P<0.01). Occlusive carotid lesions had
significantly higher MMP-9 expression than similar lesions
in the femoral arteries (Fig. 5). However, no differences in
the total collagen content nor in other MMPs and TIMP-1
expression could be demonstrated between similar lesions
in relation to the vascular bed.
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Fig. 3. Immunohistochemical and sirius red staining photographed under polarized light, of occlusive (panels A–C) and aneurysm (panels D–F) lesions.
Weak positive signal for MMP-1 (panel A) and MMP-3 (panel C) expression is shown in occlusive lesion, in contrast to extense MMP-1 (panel D) and
MMP-3 (panel F) expression in aneurysms. Total collagen was markedly reduced in aneurysm (Panel E) as compared with occlusive lesion (panel B).
4. Discussion
The MMPs family of enzymes contributes to both normal
and pathological tissue remodeling. Inappropriate remodel-
ing underlies the pathogenesis of advanced atherosclerotic
plaques, the substrate for acute cardiovascular syndromes,
including acute myocardial infarction, stroke and peripheral
arterial disease [20]. Our data demonstrate the differences
in the expression of one or more MMPs might influence
the type of lesion, therefore, determining the final evolution
of the advanced atherosclerotic plaque. We also show the
regional differences in the vascular bed involved might ac-
count for a different proteolytic pattern in the atherosclerotic
lesion.
As compared with control arteries, advanced vascu-
lar lesions showed overexpression of MMP-1, -3, -9 and
TIMP-1 throughout the atherosclerotic plaque, predomi-
nantly within the shoulder region, colocalizing with the
presence of macrophage infiltrating cells, a characteristic
feature of unstable atherosclerotic plaques [5,21]. Collagen
is the major component of the ECM of the vessel wall and
comprises up to 60% of total protein. The collagen fibers
being responsible for tensile strength and elastic resiliance
are mainly composed of types I and III collagen. We found
that overexpression of MMPs in advanced lesions was asso-
ciated with a reduced proportion of type III collagen, most
likely weakening the plaque structure [22]. These data are
consistent with a growing body of evidence showing that
MMPs expression is restricted to specific plaque regions,
influencing plaque development, composition and stability
[5,21,23].
However, higher MMPs/TIMP-1 expression was observed
in aneurysm as compared with occlusive vascular sections,
MMP-1 and-3 being significantly increased in aneurysm
atherosclerotic lesions. This proteolytic pattern could be
responsible for the expansive remodeling characteristic of
aneurysm lesions, rather than for determining an occlusive
atherosclerotic plaque. The observed differences could not
be attributed to a particular cardiovascular risk factor be-
cause the presence of dyslipidemia, arterial hypertension,
diabetes and smoking, were similar between both groups.
There are conflicting reports on the expression of MMPs in
relation to aneurysms [7–10], but in general, the majority of
the studies have reported the involvement of at least MMP-2
and MMP-9 in abdominal aortic aneurysms [24]. A novel
finding of our study was an increased expression of MMP-1
and-3, but not MMP-9 in femoral aneurysms, suggesting
that regional differences in the proteolytic mechanisms may
be operating in different arterial beds. Whether MMP-1
and-3 are causally related to the presence of aneurysm in
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Fig. 4. Immunostaining for TIMP-1 (panels A, C) and collagen (panels B, D) in calcified lesions from carotid (panels A, B) and femoral (panels C, D)
arteries. Extensive positive signal for TIMP-1 was associated with calcification areas, both in carotid (panel A) and femoral (panel C) arteries, associated
with type I collagen (panels B, D).
the femoral territory is, at present, unknown. MMP-1 has
been related to cardiac hypertrophy, dilation and systolic
dysfunction in the hearts of transgenic mice [25]. On the
other hand, MMP-3 would contribute to plaque destabiliza-
tion by degrading ECM components, and could also pro-
mote aneurysm formation by degrading the elastic lamina
[9]. These effects may be directly mediated by MMP-3 or
by activation of other proMMPs [7].
Interestingly, for the first time, we show that TIMP-1
expression was mainly increased in fibrocalcific lesions,
suggesting a possible role of TIMP-1 in arterial calcifica-
tion. The degree of vascular calcification has been shown
to correlate with plaque burden. However, it is uncertain
whether calcification is a marker for plaque instability
[26]. Recent studies showing that pharmacological inhi-
bition of MMPs attenuates ventricular dilation, increases
collagen content, and stabilizes atherosclerotic plaque,
lead us to speculate that TIMP-1, a natural inhibitor of
MMPs, could well provide protection against plaque in-
stability [13,27,28]. The observed correlation between
TIMP-1 and increased type I collagen would also support
a role for this inhibitor in the maintenance of vascular
integrity.
As compared with femoral arteries, carotid occlusive
atherosclerotic lesions showed higher MMP-9 expression.
There are no studies directly assessing the expression of
different MMPs and TIMPs in separated regions of the
arterial tree. Blood vessels have long been known to have
many organ-specific properties [29], which might partially
explain the regional differences in atherosclerotic lesions.
The diversity of cell functions may be important in phys-
iology and pathophysiology, allowing different responses
within or between vascular beds [30]. As to whether high
MMP-9 (gelatinase B) expression could determine a dif-
ferent evolution of the atheroslerotic lesion in the carotid
territory in relation to other peripheral atherosclerotic-prone
sites is unknown at present. Despite this different prote-
olytic pattern regarding the vascular beds analyzed, the total
plaque collagen content was not changed significantly. It
can be argued that the main substrates for MMP-9, gelatin
and collagen types IV and V, are not directly detected by
sirius red staining. Moreover, most of carotid arteries (ten
out of 11) showed calcification areas and, therefore, also
overexpression of TIMP-1. Therefore, since overall prote-
olytic activity depends on the relative concentration of the
active enzymes and their inhibitors [12], we could speculate
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Fig. 5. Immunostaining for MMP-9 in carotid (panel A) and femoral (panel B) arteries with occlusive lesions. Panel C shows the percentage for the
MMP-9 semiquantitative score comparing carotid and femoral arteries. *, P<0.05 as compared with femoral occlusive lesions.
that the upregulation of TIMP-1 in carotid plaques would
counterbalance the process of collagen digestion.
Our study has some limitations. Other MMPs are also
playing a role in arterial advanced atherosclerotic plaques.
In immunohistochemical staining, the presence of MMPs
assessed by immunohistochemistry does not imply increased
catalytic capacity [31]. In addition, matrix catabolism in
the cardiovascular system involves enzymes other than the
MMP family, like catepsins and cystatins. Finally, a causal
relationship between matrix degrading action and plaque
rupture has yet to be demonstrated.
In conclusion, we show that a different vascular pro-
teolytic pattern is present in occlusive as compared with
aneurysm atherosclerotic disease. We also showed differ-
ences in the vascular proteolytic pattern in relation to the
vascular bed involved. Further studies are warranted to as-
sess whether the observed differences might determine the
evolution of advanced human atherosclerotic plaques and
contribute to the vulnerability of atherosclerotic lesions.
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